Items where Author is " Zielinski Christoph"

Agrawal Yash N and Fernandez-Martinez Aranzazu and Gil-Gil Miguel and Zielinski Christoph and Ruiz-Borrego Manuel and Ciruelos Eva Maria and Munoz Montserrat and Margeli Mireia and Bermejo Begona and Anton Antonio and Kahán Zsuzsanna and Csöszi Tibor and Alonso-Romero Jose Luis and Garcia-Saenz Jose Angel and Sanchez-Rovira Pedro and Alvarez Elena and Chacon Jose Ignacio and Gonzalez-Santiago Santiago and Rodriguez Cesar A and Servitja Sonia and Pfefferle Adam D and Herranz Jesus and Liu Yuan and Carey Lisa A and Romero-Camarero Isabel and Caballero Rosalia and Guerrero-Zotano Angel and Perou Charles M and Martin Miguel: Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
JCO PRECISION ONCOLOGY, 9. ISSN 2473-4284 (2025)

Pascual Javier and Gil-Gil Miguel and Proszek Paula and Zielinski Christoph and Reay Alistair and Ruiz-Borrego Manuel and Cutts Rosalind and Ciruelos Gil Eva M and Feber Andrew and Muñoz-Mateu Montserrat and Swift Claire and Bermejo Begoña and Herranz Jesus and Kahán Zsuzsanna and Csöszi Tibor: Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.
CLINICAL CANCER RESEARCH, 29 (20). pp. 4166-4177. ISSN 1078-0432 (2023)

Thallinger Christiane and Berzinec Peter and Bicakcic Emina and Dan Adelina and Fábián Gabriella and Gales Laurentia Nicoletta and Kuhar Cvetka Grasic and Janzic Urska and Kahán Zsuzsanna and Mencinger Marina and Penthedourakis George and Sgouros Joseph and Simetic Luka and Sirbu Daniela and Vosmik Milan and Wrona Anna and Zielinski Christoph: Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe An initiative of the Central European Cooperative Oncology Group (CECOG).
WIENER KLINISCHE WOCHENSCHRIFT: MIDDLE EUROPEAN JOURNAL OF MEDICINE, 134 (19-20). pp. 697-704. ISSN 0043-5325 (2022)

Martin Miguel and Zielinski Christoph and Ruiz-Borrego Manuel and Carrasco Eva and Ciruelos Eva M. and Munoz Montserrat and Bermejo Begona and Margeli Mireia and Csoszi Tibor and Anton Antonio and Turner Nicholas and Casas Maria I and Morales Serafin and Alba Emilio and Calvo Lourdes and De La Haba-Rodriguez Juan and Ramos Manuel and Murillo Laura and Santaballa Ana and Alonso-Romero Jose L. and Sanchez-Rovira Pedro and Corsaro Massimo and Huang Xin and Thallinger Christiane and Kahán Zsuzsanna and Gil-Gil Miguel: Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 168. pp. 12-24. ISSN 0959-8049 (2022)

Zielinski Christoph and Láng István and Beslija Semir and Kahán Zsuzsanna and Inbar Moshe J. and Stemmer Salomon M. and Anghel Rodica and Vrbanec Damir and Messinger Diethelm and Brodowicz Thomas: Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.
BRITISH JOURNAL OF CANCER, 114. pp. 163-170. ISSN 0007-0920 (2016)

Brodowicz Thomas and Láng István and Kahán Zsuzsanna and Greil R. and Beslija Semir and Stemmer Salomon M. and Kaufman B. and Petruzelka L. and Eniu A. and Anghel Rodica and Koynov K. and Vrbanec Damir and Pieńkowski Tadeusz and Melichar B. and Spanik S. and Ahlers S. and Messinger Diethelm and Inbar Moshe J. and Zielinski Christoph: Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
BRITISH JOURNAL OF CANCER, 111 (11). pp. 2051-2057. ISSN 0007-0920 (2014)